XBiotech Inc. (XBIT) Financials

XBIT Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 139.8 million 4.8 million
Dec. 31, 2025 150.1 million 9.7 million
Sept. 30, 2025 172.4 million 5.3 million
June 30, 2025 178.7 million 5.6 million

XBIT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -9.0 million ?
Dec. 31, 2025 -23.0 million 162000
Sept. 30, 2025 -4.4 million 24000
June 30, 2025 -6.0 million 107000

XBIT Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 -5.5 million
Dec. 31, 2025 -26.9 million
Sept. 30, 2025 -6.0 million
June 30, 2025 -1.8 million

XBIT Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 115.5 million - -
Dec. 31, 2025 125.6 million - -
Sept. 30, 2025 147.4 million - -
June 30, 2025 152.9 million - -

XBIT Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 30.5 million
Dec. 31, 2025 30.5 million
Sept. 30, 2025 30.5 million
June 30, 2025 30.5 million

XBIT Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 5.2 million 1.1 million -
Dec. 31, 2025 34000 25.4 million 4.4 million -
Sept. 30, 2025 110000 5.1 million 967000 -
June 30, 2025 51000 5.3 million 1.0 million -

XBIT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 332000
Dec. 31, 2025 - 378000
Sept. 30, 2025 - 427000
June 30, 2025 - 439000

XBIT Revenue by Segment
Graph available only for paid members. Upgrade to see it.

XBIT

Price: $2.31

52 week price:
2.09
3.61

Payout Ratio Range:
-2300.00%
-1159.78%

Earnings Per Share: -1.49 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 35800

Ebitda: -47.9 million

Market Capitalization: 72.3 million

Links: